Multiple Organ Failure: Clinical Trials

13 trials for Multiple Organ Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 4 unknown, 2 terminated, 1 not yet recruiting. 13 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 413Completed 5, Unknown 4, Terminated 2, Not yet recruiting 1, Recruiting 1

Follow Multiple Organ Failure: new trials by email Literature Review of Multiple Organ Failure trials Research Report on Multiple Organ Failure

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection
Conventional treatment, Sivelestat sodium, Placebo - Type A Aortic Dissection, Organ Failure, Multiple
Phase 4Not yet recruitingShanghai Zhongshan Hospital2362025-09-012025-09-05
Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)
Indomethacin SR, Placebos - Acute Pancreatitis, Complication
Phase 4RecruitingPeking Union Medical College Hospital15042024-12-012025-06-15
Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients
Initiation of vasopressine as a first vasoconstrictive drug, Initiation of noradrenaline as a first vasoconstrictive drug - Circulatory Shock
Phase 4UnknownUniversity of Thessaly1452023-12-152024-03-06
Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality
Ulinastatin - Severe Sepsis, Septic Shock
Phase 4UnknownJinnah Postgraduate Medical Centre1752023-05-012023-06-08
Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19
Dexamethasone - Acute Respiratory Distress Syndrome Caused by COVID-19
Phase 4TerminatedHospital Universitario de Gran Canaria Doctor Negrín192020-04-032021-02-03
GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study
GM-CSF - Pediatric Sepsis-induced MODS
Phase 4CompletedNationwide Children's Hospital752018-12-052026-05-05
The Pharmacokinetics of Fentanyl in Intensive Care Patients
Fentanyl - Multiple Organ Failure, Critical Care
Phase 4UnknownOslo University Hospital1502015-10-012015-10-29
Pharmacokinetics of Two Different High-dose Regimens of Intravenous Vitamin C in Critically Ill Patients
Ascorbic Acid - Multiple Organ Failure, Sepsis
Phase 4CompletedAmsterdam UMC, location VUmc202015-03-012017-08-02
Modulation of Systemic Inflammatory Response in Critically Ill Children After Glutamine Supplementation
solution of amino acids supplemented with glutamine, amino acids not supplemented with glutamine - Inflammatory Response, Multi-organ Failure
Phase 4CompletedHospital Sant Joan de Deu1012010-04-012013-09-06
Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration
CVVH 4 to 2 L/h, CVVH 2 to 4L/h - Kidney, Acute Renal Failure
Phase 4CompletedOnze Lieve Vrouwe Gasthuis142007-02-012009-08-25
Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
intravenous (IV) ganciclovir - Acute Renal Failure, Cytomegalovirus Infections
Phase 4TerminatedUniversity of Oslo School of Pharmacy62005-12-012007-06-28
6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
6-methyl-prednisolone - Multiple Organ Dysfunction Syndrome
Phase 4UnknownHospital Universitario Principe de Asturias2402005-08-012008-05-13
Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis
venovenous hemofiltration - Bacteremia, Gram-Negative Bacterial Infections
Phase 4CompletedHopital Lariboisière4001997-03-012006-12-04

Narrower conditions

Sepsis (4)  ·  Acute Kidney Injury (2)  ·  Shock, Septic (2)  ·  Bacteremia (1)  ·  COVID-19 (1)  ·  Cytomegalovirus Infections (1)  ·  Diabetes Insipidus (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Hyperphagia (1)  ·  Pancreatitis (1)  ·  Pneumonia, Bacterial (1)  ·  Shock (1)  ·  Systemic Inflammatory Response Syndrome (1)

Broader conditions

Pathologic Processes (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Shock (12)  ·  Infections (7)  ·  Inflammation (4)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Systemic Inflammatory Response Syndrome (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Lung Diseases (2)  ·  Pneumonia (2)  ·  Renal Insufficiency (2)

Interventions

Ascorbic Acid (1)  ·  Colony-Stimulating Factors (1)  ·  Continuous Renal Replacement Therapy (1)  ·  Dexamethasone (1)  ·  Fentanyl (1)  ·  Ganciclovir (1)  ·  Glutamine (1)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (1)  ·  Hemofiltration (1)  ·  Norepinephrine (1)  ·  alanylglutamine (1)  ·  amino-acid, glucose, and electrolyte solution (1)  ·  methyl 11,17,21-trihydroxy-3,20-dioxopregna-1,4-diene-16-carboxylate (1)  ·  salicylhydroxamic acid (1)  ·  sargramostim (1)

Sponsors

Amsterdam UMC, location VUmc (1)  ·  Hopital Lariboisière (1)  ·  Hospital Sant Joan de Deu (1)  ·  Hospital Universitario Principe de Asturias (1)  ·  Hospital Universitario de Gran Canaria Doctor Negrín (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  Nationwide Children's Hospital (1)  ·  Onze Lieve Vrouwe Gasthuis (1)  ·  Oslo University Hospital (1)  ·  Peking Union Medical College Hospital (1)  ·  Shanghai Zhongshan Hospital (1)  ·  University of Oslo School of Pharmacy (1)  ·  University of Thessaly (1)

Countries

Spain (3)  ·  China (2)  ·  Netherlands (2)  ·  Norway (2)  ·  France (1)  ·  Greece (1)  ·  Pakistan (1)  ·  United States (1)

Top investigators

Anders Hartmann, MD, Ph.D. (1)  ·  Baofeng Zhu, MD (1)  ·  Daoyuan Jing, MD (1)  ·  Didier Payen, MD, PhD (1)  ·  Dong Wu, M.D. (1)  ·  H.M. Oudemans-van Straaten, MD, PhD (1)  ·  Heleen Oudemans-van Straaten, MD.PhD (1)  ·  Hong Liu, MD (1)  ·  Iolanda Jordan, PhMD (1)  ·  Jan F Bugge, MD, Ph.D. (1)  ·  Jianzhong Yang, MD (1)  ·  Mark W Hall, MD (1)  ·  Mei Liu, M.D. (1)

Results publications

PMID 12794416, PMID 18305265, PMID 19958532, PMID 25872171, PMID 27449641, PMID 27483065, PMID 28820036, PMID 29522710, PMID 29600824, PMID 32043986, PMID 32799933, PMID 33314078, PMID 34519356, PMID 34605781, PMID 36018257, PMID 36416787

NIH funding

2014 (1)